Sympomed Spółka z Ograniczoną Odpowiedzialnością (KRS 0000744292, NIP 7811978559) is a Polish company, headquartered in Poznań, Wielkopolskie voivodeship. SYMPOMED operates in: Organisation of conventions and trade shows (PKD 82.30.Z). Industry: Office administration. The company has been listed in the National Court Register since August 13, 2018. SYMPOMED's most recently reported net revenue was 288.0 K PLN for 2024.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Sympomed
Identity
- Name
- Sympomed Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- August 13, 2018
- Registry status as of
- November 21, 2025
- Latest entry
- June 14, 2025
- Founding act
- 08.08.2018 R.
Articles of association history (2)
- August 8, 2018: 08.08.2018 R.
- April 9, 2021: 09.04.2021 R., REP. A NR 2022/2021, NOTARIUSZ JĘDRZEJ BASIŃSKI KANCELARIA NOTARIALNA W POZNANIU, UL. JACKOWSKIEGO 13/1, 60-508 POZNAŃ, ZMIENIONO: § 13 USTR. 2 UMOWY SPÓŁKI
Activities
Main activity
82.30.ZOrganisation of conventions and trade shows
Address and contact
- Address
- UL. HENRYKA SIENKIEWICZA, 5, 3, 60-816, POZNAŃ, POLSKA
- Voivodeship
- WIELKOPOLSKIE
- District
- POZNAŃ
- WERONIKA.SYMBORA@GMAIL.COM
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-61360-13974-FATJU-31
- Coordinates
- 52.4079, 16.9335approx.
Risk and payment profile - Sympomed
Credibility rating
32.4 / 100
Poor credibility
Insolvency risk
Low
Elevated threat
Closure risk
21
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
2
2/8 yrs
Board changes
1
1/8 yrs
PKD changes
0
0/8 yrs
Name changes
0
0/8 yrs
Data from 8 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: E (32/100)
Trend: deteriorating (-10.7 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2024
Current: 4.6 K PLN
Safe: 919.48 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Sympomed
Founded
August 13, 2018
7 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
POZNAŃ
WIELKOPOLSKIE
Primary PKD
82.30.Z
Organisation of conventions and trade shows
Share capital
5.0 K PLN
100 shares total
Shareholders
3
shareholders
Board
2 people
Filed years
6 years
2018–2024 · profitable: 3/6
Registry entries
24
latest: June 14, 2025
Risk signals
Revenue
288.0 K PLN
2024
Net profit
-1.2 K PLN
2024
Assets
23.0 K PLN
2024
Equity
7.2 K PLN
2024
EBITDA
-1.9 K PLN
2024
Valuation
49.0 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Sympomed.
No ratings
Related articles
News
EKG 2026 Katowice: every PLN 1 invested in climate adaptation yields at least PLN 12 in savings
At the European Economic Congress in Katowice, the new National Climate Adaptation Strategy was presented. The headline number: every PLN 1 invested in adaptation generates at least PLN 12 in savings - a signal for local governments and the insurance sector.
News
Kruk SA recommends PLN 18 dividend per share - around PLN 340 m in total, Poland's leader in NPL debt collection with operations in 5 EU countries
The Kruk SA management board recommends PLN 18 per share from 2025 profits - around PLN 340 m in total. It continues a policy distributing roughly 50% of net profit, supported by expansion in Italy, Romania, Spain, and Germany. At the current price of about PLN 520 the dividend yield reaches approximately 3.5%. Ownership is dispersed - mainly OFE pension funds, investment funds, and free float, with no State Treasury stake and no dominant strategic investor.